It might be advantageous to know whether the accuracy depends on the TaS; however, it appears unlikely as we did not find any hint on the TaS having any influence at all on [18F]F-PSMA uptake in primary tumor, local recurrence or prostate cancer metastases. The gene discussed is FOLH1; the disease is prostate cancer.